Politico January 4, 2026
Most Americans, who have private insurance, likely will not benefit immediately from efforts to lower prescription drug prices. Administration officials expect effects to spread as markets are reshaped.
President Trump last week touted his pricing deals with 14 drugmakers as “the greatest victory for patient affordability in the history of American health care, by far.”
The drug-pricing deals can undoubtedly be seen as political wins at a time when Democrats are pounding the White House over high prices. They will save Medicaid money in the short run, allow Americans to buy discounted drugs with cash directly from drug companies and boost domestic pharmaceutical manufacturing.
But will most Americans feel like the deals make their lives more affordable?
The answer is...
Today's Sponsors
Today's Sponsor